Eugene to research the formulation of the new SFX-01 pill | Tech Reddy
[ad_1] The therapy allows the treatment of neurological and oncological diseases Eugen – the company developing the sulforaphane-based treatment – found that it dosed the first group of healthy volunteers in a placebo-controlled, dose-escalating phase 1/1b clinical trial of SFX-01. The therapy is a patented combination of synthetic sulforaphane and alpha-cyclodextrin. The … Read more